Literature DB >> 18001256

Treatment of Mycobacterium marinum cutaneous infections.

Efstathios Rallis1, Elma Koumantaki-Mathioudaki.   

Abstract

Mycobacterium marinum is a non-tuberculous mycobacterium found in non-chlorinated water, with worldwide prevalence. It is the most common atypical Mycobacterium that causes opportunistic infection in humans. It presents as a solitary, red-to-violaceous plaque or nodule with an overlying crust or verrucous surface, or as inflammatory nodules or abscesses, usually in a sporotrichotic type of distribution. Deep infections may also occur. Although diagnosis is confirmed by isolation and identification of the organism in practice diagnosis remains largely presumptive based on clinicohistological features and the response to treatment. Polymerase chain reaction allows the routine early detection of the organism from a biopsy specimen. In the near future, it seems possible that histopathological examination might be greatly assisted by the rapidly improving possibilities with in vivo imaging. There have been many therapeutic modalities used effectively in the treatment of M. marinum infections. Spontaneous remission has also been reported in untreated infections and in immunocompetent hosts. However, there is no proven treatment of choice because M. marinum is naturally multi-drug resistant species and treatment is based primarily on the personal experience and preference of individual investigators, without the benefit of large studies. In superficial cutaneous infections minocycline, clarithromycin, doxycycline and trimethoprim-sulfamethoxazole as monotherapy are effective treatment options, but drug resistance varies and thereby combination therapy usually of two drugs may be required. Ciprofloxacin has shown considerable effectiveness. In cases of severe infections, including those with a sporotrichoid distribution pattern, a combination of rifampicin and ethambutol seems to be the recommended regimen. The use of isoniazid, streptomycin and pyrazinamide as empirical treatment options should be avoided. Surgical treatment is not usually recommended and must be cautiously applied. Cryotherapy, X-ray therapy, electrodesiccation, photodynamic therapy and local hyperthermic therapy have been reported as effective therapeutic alternatives. M. marinum infection should always be included in the differential diagnosis of all cases with poor-healing wounds in upper extremities and a history of exposure to aquariums.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18001256     DOI: 10.1517/14656566.8.17.2965

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  25 in total

Review 1.  [Infections due to Mycobacterium marinum: a review].

Authors:  P Nenoff; B-M Klapper; P Mayser; U Paasch; W Handrick
Journal:  Hautarzt       Date:  2011-04       Impact factor: 0.751

2.  Mycobacterium marinum infection from sea monkeys.

Authors:  Jaclyn Leblanc; Duncan Webster; Gregory J Tyrrell; Isabelle Chiu
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

Review 3.  Photodynamic therapy for infections: clinical applications.

Authors:  Gitika B Kharkwal; Sulbha K Sharma; Ying-Ying Huang; Tianhong Dai; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

4.  Inactivation of tesA reduces cell wall lipid production and increases drug susceptibility in mycobacteria.

Authors:  Sivagami Sundaram Chavadi; Uthamaphani R Edupuganti; Olivia Vergnolle; Itrat Fatima; Shaneen M Singh; Clifford E Soll; Luis E N Quadri
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

Review 5.  Effects of Curcumin and Its Analogues on Infectious Diseases.

Authors:  Reza Ranjbar; Hossein Bagheri; Faezeh Ghasemi; Paul C Guest; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Pleiotropic consequences of gene knockouts in the phthiocerol dimycocerosate and phenolic glycolipid biosynthetic gene cluster of the opportunistic human pathogen Mycobacterium marinum.

Authors:  Poornima Mohandas; William C Budell; Emily Mueller; Andrew Au; Glennon V Bythrow; Luis E N Quadri
Journal:  FEMS Microbiol Lett       Date:  2016-01-26       Impact factor: 2.742

7.  Nasal fish tank granuloma: an uncommon cause for epistaxis.

Authors:  Wan-Ling Ho; Wen-Yu Chuang; An-Jing Kuo; Kai-Chieh Chan
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

8.  Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.

Authors:  Daniel P O'Brien; Anthony McDonald; Peter Callan; Mike Robson; N Deborah Friedman; Andrew Hughes; Ian Holten; Aaron Walton; Eugene Athan
Journal:  PLoS Negl Trop Dis       Date:  2012-01-17

9.  Diagnosis of Mycobacterium marinum Infection with Sporotrichoid Pattern.

Authors:  Diana Isabela Costescu Strachinaru; Peter Vanbrabant; Patricia Stinga; Mihai Strachinaru; Patrick Soentjens
Journal:  Acta Derm Venereol       Date:  2021-03-11       Impact factor: 3.875

10.  Fish tank granuloma caused by Mycobacterium marinum.

Authors:  Ting-Shu Wu; Cheng-Hsun Chiu; Chih-Hsun Yang; Hsieh-Shong Leu; Ching-Tai Huang; Yi-Chieh Chen; Tsu-Lan Wu; Pi-Yueh Chang; Lin-Hui Su; An-Jing Kuo; Ju-Hsin Chia; Chia-Chen Lu; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.